The main market opportunities in Syndromic Multiplex Diagnostics include the merging of Point of Care Testing and Molecular Diagnostics, which is streamlining frontline test protocols while reducing ...

Key opportunities in the Human Metapneumovirus Diagnostics Market include the growing use of multiplex testing panels for ...

The COVID-19 pandemic led to a disruption of infection rates of many common respiratory diseases in children. However, the ...

Emerging opportunities in diagnostics include rapid and point-of-care testing, consumer markets, and biomarker development. Immunoassays are expanding due to genetic advances, with multiplex becoming ...

Emerging technologies and niche markets are transforming latent TB diagnostics, with significant growth in certain segments. Disruptive innovations may alter market dynamics, highlighting new leaders ...

Vanderbilt University announced seven recipients of the Innovation Catalyst Fund awards for the October 2025 cycle. The awards offer strategic ...